1. Long-term results of choroidal neovascularization secondary to angioid streaks.
- Author
-
Mori H, Yamada H, and Takahashi K
- Subjects
- Aged, Angiogenesis Inhibitors administration & dosage, Angioid Streaks diagnosis, Angioid Streaks drug therapy, Choroidal Neovascularization diagnosis, Choroidal Neovascularization drug therapy, Female, Follow-Up Studies, Fundus Oculi, Humans, Intravitreal Injections, Male, Prognosis, Retrospective Studies, Time Factors, Angioid Streaks complications, Choroidal Neovascularization etiology, Fluorescein Angiography methods, Tomography, Optical Coherence methods, Visual Acuity
- Abstract
Purpose: To investigate factors contributing to the visual prognosis of choroidal neovascularization (CNV) secondary to angioid streaks (AS) in a long-term follow-up (> 5 years) study., Methods: Twenty-one patients (32 eyes) affected by CNV secondary to AS were enrolled retrospectively and divided into three groups according to the period of CNV recurrence from the final treatment: group A, no recurrence for more than 12 months; group B, no recurrence for 6-12 months; and group C, no recurrence for < 6 months or ongoing. According to the above classification, we assessed best-corrected visual acuity (BCVA), peau d'orange area, the number of photodynamic treatments and/or intravitreal antiangiogenic drug injections, central choroidal thickness (CCT) and central retinal thickness (CRT) using optical coherence tomography, and enlargement of retinal pigment epithelium (RPE) atrophy., Results: The median follow-up time was 91 months. The median logarithm of the minimum angle of resolution BCVA significantly deteriorated from 0 at baseline to 1 at final follow-up (p < 0.05). Especially, final BCVA in group A showed worst visual outcome despite lowest number of treatments. Peau d'orange areas at baseline were found in 32 eyes (100%). There were no significant differences between initial CRT and final CRT. Median CCT was significantly reduced from 188 μm at baseline to 96 μm at final follow-up (p < 0.05). The median number of treatments was 3.5. Enlargement of RPE atrophy at baseline was found in 31 eyes (96.8%)., Conclusions: Despite the regression of CNV secondary to AS following treatment, the visual prognosis was poor due to the presence of peau d'orange areas, choroidal thinning, and increased RPE atrophy.
- Published
- 2020
- Full Text
- View/download PDF